Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88